
The over-the-counter sales channel for hearing aids is edging closer to becoming reality in the US, with the current timeline projecting that first sales could begin in September at the latest.
The US Food and Drug Administration (FDA) has been gathering hearing responses and industry feedback from other stakeholders, and during the process, a number of concerns and questions about channel’s framework have been raised.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app